CropLife International Policy Perspective on Endocrine Disruptors

Posted by Dan Jacobs|28 September 2015

The growing awareness of endocrine disruptors among consumers, politicians and scientists rightfully has many crop protection companies concerned about regulations that might impact their operations.

Ahead and in anticipation of and public or political outcry, CropLife International released its Policy Perspective on Endocrine Disruptors, which argues current crop protection product regulations ensure high levels of protection for human health and the environment. This includes regulatory testing for endocrine-mediated effects that are scientifically strong and sufficient to support regulatory decision-making.The report has been released as the crop protection industry takes part in the fourth session of the International Conference on Chemicals Management in Geneva.

“The continued protection of human health and the environment results from science- and risk-based policymaking,” said Howard Minigh, President and CEO of CropLife International. “Using hazard-based decision-making fails to take into account all relevant scientific data and does not provide a rational basis for regulatory decision-making.”

Read CropLife International’s Policy on Endocrine Disruptors.